Promethazine and Etoposide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Promethazine (promethazine hydrochloride) and Etoposide (etoposide). Common drug interactions include neutrophil count decreased among females and dystonia among males.
The phase IV clinical study analyzes what interactions people have when they take Promethazine and Etoposide. It is created by eHealthMe based on reports of 97 people who take the same drugs from the FDA, and is updated regularly.
What is Promethazine?
Promethazine has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 32,300 Promethazine users. Check the latest studies of Promethazine.
What is Etoposide?
Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
97 people who take Promethazine and Etoposide together, and have interactions are studied.

What are the common drug interactions of Promethazine and Etoposide, by gender? *:
female:
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Chest pain
- Death
- Hypocalcaemia (levels of calcium in blood serum are abnormally low)
- Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
- Pyrexia (fever)
- Aphasia (damage to the parts of the brain that control language)
- Dysarthria (speech disorder)
- Headache (pain in head)
- Medulloblastoma recurrent (reoccurrence of a fast-growing, high-grade tumour that always begins in the cerebellum)
male:
- Dystonia (abnormal muscle tone)
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- White blood cell count decreased
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Peripheral swelling
- Feeding disorder (when children refuse to eat certain food groups)
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Myelosuppression (a decrease in the production of blood cells)
- Platelet count decreased
- Urinary tract infection
What are the common drug interactions of Promethazine and Etoposide, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Dystonia (abnormal muscle tone)
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Engraftment syndrome (inflammatory condition during neutrophil recovery after hematopoietic stem cell transplantation)
- Electrolyte imbalance
- Dehydration (dryness resulting from the removal of water)
- Colitis (inflammation of colon)
- Eating disorder
- Mucosal inflammation (infection of mucous membrane)
- Feeding disorder (when children refuse to eat certain food groups)
- Bacteraemia (presence of bacteria in the blood)
10-19:
- Aphasia (damage to the parts of the brain that control language)
- Dysarthria (speech disorder)
- Headache (pain in head)
- Medulloblastoma recurrent (reoccurrence of a fast-growing, high-grade tumour that always begins in the cerebellum)
- Pyrexia (fever)
- Dysphagia (a condition in which swallowing is difficult or painful)
20-29:
- Cytomegalovirus infection
- Fibula fracture
- Greenstick fracture (soft bone in which the bone bends and partially breaks)
- Histiocytosis haematophagic
- Multiple fractures
- Osteopenia (a condition where bone mineral density is lower than normal)
- Osteoporosis (bones weak and more likely to break)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
30-39:
- Drug hypersensitivity
- Lip swelling
- Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
- Skin reaction
- Swollen tongue (swelling of tongue)
- Throat tightness
40-49:
- Lung abscess (pus in lungs)
- Bacterial sepsis
- Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
- Drug ineffective
- Febrile neutropenia (fever with reduced white blood cells)
- Neutropenia (an abnormally low number of neutrophils)
- Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
- Pyrexia (fever)
- Refractory cancer (cancer that has not responded to treatment)
- Richter's syndrome (hairy cell cancer changes in fast growing b cell cancer tumour)
50-59:
- Platelet count decreased
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Death
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
- Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
- Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
- Back pain
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Febrile neutropenia (fever with reduced white blood cells)
60+:
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
- Pruritus (severe itching of the skin)
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Death
- White blood cell count decreased
- Peripheral swelling
- Anaemia (lack of blood)
- Myelosuppression (a decrease in the production of blood cells)
- Pneumonia
- Thrombocytopenia (decrease of platelets in blood)
What are the existing conditions these people have? *
- Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 36 people, 37.11%
- Pain: 14 people, 14.43%
- Nausea And Vomiting: 10 people, 10.31%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 8 people, 8.25%
- Constipation: 8 people, 8.25%
- Tumor: 7 people, 7.22%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 7.22%
- Lung Cancer - Small Cell (lung cancer): 6 people, 6.19%
- Insomnia (sleeplessness): 6 people, 6.19%
- Thrombocytopenia (decrease of platelets in blood): 5 people, 5.15%
* Approximation only. Some reports may have incomplete information.
Do you take Promethazine and Etoposide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Promethazine (32,300 reports)
- Etoposide (77,815 reports)
Browse all drug interactions of Promethazine and Etoposide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Promethazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Etoposide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Promethazine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Etoposide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on promethazine hydrochloride and etoposide (the active ingredients of Promethazine and Etoposide, respectively), and Promethazine and Etoposide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Spironolactone cause Crepitations? - 11 seconds ago
- Could Carafate cause Thrombocytopenia? - 27 seconds ago
- Candesartan Cilexetil and Metformin drug interactions for men aged 50-59 - 30 seconds ago
- Could Gyne-Lotrimin cause Therapeutic Response Decreased? - 41 seconds ago
- Cisplatin and Hydrocortisone drug interactions for women aged 50-59 - 43 seconds ago
- Could Tramadol Hydrochloride cause Gallstones? - 44 seconds ago
- Could Invega Sustenna cause Hypophagia? - 52 seconds ago
- Could Tylenol cause Metamyelocyte Count Increased? - a minute ago
- Folic Acid and Haemorrhagic Anaemia for Women aged 60+ - a minute ago
- Could Lovenox cause Agranulocytosis? - a minute ago